Plain and simple. If you look at history. Any time a "replacement" like this happens things do not turn out well for those companies.
John Cousins is about as honest as they come on Wall Street. He did not feel right being out in front of this messy situation and he stepped aside.
I'm placing my bet on the company that has the better, more expensive, fda approved product that is ready to go to market. Most all the risk is off the table at RPC.
Insurance companies may hate it, but doctors, labs and facilities always submit the more expensive tests for reimbursements. And as an investor I want the biggest return/potential return for my money.
It doesn't speak well that BMOD's test costs a lot less. Not in this case.
Look at the headlines and analysts. Who is talking about which company and what kind of price targets are they giving for each stock?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.